Physician profile
Thomas Peter Lindquist
NPI 1184853947
$1,402.78
in general payments reported to CMS, 2019-2025
21 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $64.83 · 2021: $113 · 2022: $198 · 2023: $143 · 2024: $281 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $239.28 | 2020-2024 | Acthar |
| Biotissue Holdings INC. | $173.49 | 2019-2024 | |
| Alcon Vision LLC | $148.09 | 2019-2025 | Rocklatan, Tryptyr |
| Glaukos Corporation | $138.17 | 2021-2025 | Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $121.25 | 2019-2021 | |
| Dompe US, INC. | $89.37 | 2019-2025 | Oxervate |
| Mallinckrodt Enterprises LLC | $54.14 | 2019 | |
| Horizon Therapeutics Plc | $43.46 | 2022 | |
| Rxsight INC | $42.86 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Aerie Pharmaceuticals, INC. | $34.43 | 2019-2020 | |
| Abbvie INC. | $27.90 | 2024 | |
| Ani Pharmaceuticals, INC. | $27.47 | 2025 | Yutiq |
| Carl Zeiss Meditec USA, INC. | $22.14 | 2023 | Artevo 800 |
| Tarsus Pharmaceuticals, INC. | $18.85 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $18.31 | 2019 | |
| Sun Pharmaceutical Industries INC. | $18.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.16 | 2021 | |
| Allergan, INC. | $15.85 | 2019 | |
| Beaver-Visitec International, INC. | $15.52 | 2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lindquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.